CN110279894A - Composite material and heart valve prosthesis based on fibroin fiber - Google Patents

Composite material and heart valve prosthesis based on fibroin fiber Download PDF

Info

Publication number
CN110279894A
CN110279894A CN201910565441.9A CN201910565441A CN110279894A CN 110279894 A CN110279894 A CN 110279894A CN 201910565441 A CN201910565441 A CN 201910565441A CN 110279894 A CN110279894 A CN 110279894A
Authority
CN
China
Prior art keywords
fibroin
composite material
film
fibroin fiber
fiber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910565441.9A
Other languages
Chinese (zh)
Inventor
张兴
郭峰
韩日峥
杨锐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Metal Research of CAS
Original Assignee
Institute of Metal Research of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Metal Research of CAS filed Critical Institute of Metal Research of CAS
Priority to CN201910565441.9A priority Critical patent/CN110279894A/en
Publication of CN110279894A publication Critical patent/CN110279894A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2415Manufacturing methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/20Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Manufacturing & Machinery (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention discloses a kind of composite material and heart valve prosthesis based on fibroin fiber, belongs to medical material tech field.Prosthese leaflet is prepared by fibroin fiber through electrostatic spinning process, can electrospinning provides the fibroin albumen membrane material leaflets of isotropism and Anisotropic Mechanical Properties respectively according to different collection modes.In addition, polyethylene glycol hydrogel is coated on fibroin fiber film surface to form composite material using optical cross-linking method.The spatial mesh structure of polyethylene glycol hydrogel protects fibroin albumen not degraded by biological enzyme, and has functions.Electrostatic spinning anisotropy fibroin protein film has Anisotropy, can imitate stress distribution of the human aortic valve under blood flow effect, realize and mechanical property similar in human body valve.

Description

Composite material and heart valve prosthesis based on fibroin fiber
Technical field
The present invention relates to medical material tech fields, and in particular to a kind of composite material and people based on fibroin fiber Work heart valve.
Background technique
Heart valve disease is a kind of common disease and frequently-occurring disease, and Cardiac valve replacement is treatment latter stage heart valve The most effective surgical means of lesion.The replacement valve clinically used at present is mainly mechanical valve prosthesis (stainless steel, pyrolyzed carbon materials Deng) and biovalve (Pigs Hearts packet, bovine pericardial material etc.), however these materials lead to a series of ask after being chronically implanted human body Topic and corresponding complication.Mechanical valve prosthesis material surface is easily formed thrombus, thus it is postoperative need to take anticoagulation medicine throughout one's life, And the problems such as biovalve is also easily decayed and calcification, is shorter so as to cause its service life.In recent years, with macromolecule The continuous development of materialogy, more and more polymer-based materials are studied the preparation that personnel are applied to heart valve prosthesis.20 Macromolecule heart valve, past successfully are implanted in the aorta petal of human body and mitral position for the first time the sixties in century Over 50 years, the macromolecule heart valve of many different materials types is devised, has specifically included that polysiloxane-based, polyurethane Class, polytetrafluoroethyl-ne alkenes and polyethylene glycol hydrogel class.But macromolecule valve does not obtain clinical universal, many yet up to now High molecular material also faces the problems such as chronic fatigue tearing, fibroplasia and calcification.
Summary of the invention
The purpose of the present invention is to provide a kind of composite material and heart valve prosthesis based on fibroin fiber, utilization Electrostatic spinning process prepares fibroin fiber, then polyethylene glycol hydrogel cladding is formed on its surface composite material, and will Gained composite material is as heart valve prosthesis prosthese.Electrostatic spinning preparation fibroin albumen have good biocompatibility, The characteristics of good mechanical property, meets native heart valve mechanical property requirements;Fibroin fiber material surface can coat simultaneously Polyethylene glycol hydrogel, polyethylene glycol hydrogel has both good biocompatibility and anti-pollution effect, and can be effectively protected interior The fibroin albumen in portion, to reach anticalcium and resistance to enzymolysis purpose.
To achieve the above object, technical scheme is as follows:
A kind of composite material based on fibroin fiber, including fibroin fiber film and polyethyleneglycol diacrylate (poly (ethylene glycol) diacrylate, PEGDA) hydrogel has on the fibroin fiber film multiple micro- Hole, the PEGDA hydrogel are coated in fibroin fiber film both side surface, and the hydrogel has penetration type structure, That is: the PEGDA hydrogel in fibroin fiber film both side surface is connected by the micropore.
In the composite material, volume ratio shared by the fibroin fiber film is 80%-100% (preferably 80%- 95%), 100-700 μm of the film thickness of fibroin fiber film, average fibre diameter 200-500nm.
Micropore on the fibroin fiber film is uniformly distributed, and aperture is 100-150 μm, pitch-row 1-2mm.
The fibroin fiber film is to be prepared using silk as raw material using electrostatic spinning process, the electrostatic In spinning technique: spinning voltage range is 1-33kV, and spinning receives distance 10-20cm, and spinning fltting speed is 0.1-0.15mm/ min;During spinning, when reception device is aluminum baffle, isotropism fibroin protein film is obtained;Reception device is aluminum roller When (revolution: 2000-3000rpm), anisotropy fibroin protein film is obtained.
When the fibroin fiber film is isotropism fibroin fiber film, isotropism arrangement is presented in fiber;Institute State fibroin fiber film be anisotropy fibroin fiber film when, fiber present anisotropy arrangement;The isotropism The elasticity modulus of fibroin fiber film is 6-8MPa;In the anisotropy fibroin fiber film, it is parallel to machine direction Elasticity modulus 13-18MPa is 1-4MPa perpendicular to machine direction elasticity modulus.
The composite material based on fibroin fiber is by photo-crosslinking method that PEGDA hydrogel is coated in fibroin Azelon film surface obtains, which includes the following steps:
(1) pretreatment of fibroin fiber film: penetration type punching is carried out to fibroin protein film, obtains multiple be uniformly distributed Micropore, avoid being layered and increasing its connectivity;Fibroin protein film after punching is immersed in the poly- second two containing photoinitiator Alcohol diacrylate (poly (ethylene glycol) diacrylate, PEGDA) in advance in glue solution, be put into vacuum hold Make to be completely filled with the pre- gelling solution of PEGDA in the fiber mesh and hole (micropore) of fibroin protein film in device;The PEGDA in advance at In sol solution, polyethyleneglycol diacrylate concentration is 20-30wt.%, and photoinitiator is Irgacure2959 (2-hydroxy- 40- (2-hydroxyethoxy) -2-methylpropiophe-none), photoinitiator concentration 1-5g/L.
(2) dimethyl silicone polymer (polydimethylsiloxane, PDMS) template of size and thickness needed for preparing, The PDMS template, which is placed on, a piece of to be hadOn the glass slide of coating, after then placing pretreatment in PDMS template Fibroin fiber membrane sample, be supplemented the pre- gelling solution of PEGDA and fill up PDMS template central clear region, then in PDMS Another is covered above template hasThe glass slide of coating seals;
(3) reaction is crosslinked using cool white light or ultraviolet light, until forming the coated fibroin of polyethylene glycol hydrogel The composite material of protein film.
It is compound when polyethylene glycol hydrogel is coated when isotropism fibroin fiber film surface in the composite material Elasticity modulus of materials is 4-6MPa;It is compound when polyethylene glycol hydrogel is coated when anisotropy fibroin fiber film surface Material still maintains Anisotropy, in which: machine direction elasticity modulus 11-15MPa is parallel to, perpendicular to machine direction bullet Property modulus be 1-4MPa.
By the composite material sewing based on fibroin fiber in internal stent, it is fine to obtain anisotropy fibroin albumen Tie up composite material heart valve prosthesis prosthese.The heart valve prosthesis prosthese has excellent flow dynamics, effectively Opening area 1.5-2.7cm2, backflow than < 20%.
Compared with existing heart valve prosthesis prosthese, the beneficial effects of the present invention are embodied in:
1, the present invention has biocompatibility using fibroin protein film as inner layer material and realizes similar with human body valve Mechanical property;Cladding PEGDA hydrogel can also provide good biocompatibility and antifouling property, and protect the fibroin egg of internal layer White fiber is not degraded by enzymes.
2, the present invention prepares fibroin fiber material with electrospinning process, wherein anisotropic fibroin protein film energy The Anisotropic Mechanical Properties for enough imitating natural valve, enhance the radial compliance and circumferential strength of artificial leaflet, to obtain Better flow dynamics and long-term fatigue durability.
3, the present invention can prepare diverse microcosmic appearance (fiber orientation, fibre diameter) and ruler by electrostatic spinning process The complex layered heart valve prosthesis of very little (thickness of sample, size) is, it can be achieved that heart valve prosthesis customizes.
Detailed description of the invention
Fig. 1 is the stereoscan photograph of the double-deck fibroin fiber membrane material of electrostatic spinning preparation;Wherein: the figure left half Portion is material upper surface (anisotropy), and right side is material lower surface (isotropism).
Fig. 2 is the anisotropy bilayer fibroin albumen composite material of the polyethylene glycol hydrogel package of preparation;Wherein: (a) Composite structure schematic diagram is illustrated including fibroin protein film penetration type punch position schematic diagram and composite material section Figure;(b) stereoscan photograph of composite material.
Fig. 3 is to use anisotropy bilayer fibroin fiber film and mass percent concentration for 20%PEGDA solution system The mechanical property of standby artificial heart valve film composite material;Wherein: (a) bent along machine direction and perpendicular to the stretching of machine direction Line;(b) along machine direction and perpendicular to the elastic mould value of machine direction.
Fig. 4 is the sewing method schematic diagram of fibroin fiber material when preparing heart valve prosthesis prosthese;Wherein: (a) Leaflet material sewing method schematic diagram, (b) leaflet material and bracket assembled method schematic diagram.
Fig. 5 is that anisotropy bilayer fibroin protein film and mass percent concentration is used to prepare for 20%PEGDA solution Rheokinetic curve under its external pulsation flow assay device of heart valve prosthesis prosthese;Wherein: (a) fluid dynamics are bent Line;(b) heart valve prosthesis moving process picture.
Fig. 6 is using its external pulsation flow assay device of the heart valve prosthesis prosthese of isotropism fibroin albumen film preparation Under rheokinetic curve.
Fig. 7 is to use the fibroin fiber membrane material prepared under the conditions of fibroin albumen concentration 20wt% and spinning voltage 23kV The stereoscan photograph of material.
Specific embodiment
Below with reference to embodiment and attached drawing, technical scheme is described further.
The present invention prepares the process of fibroin fiber composite material and heart valve prosthesis prosthese are as follows: is with silk first Raw material prepares fibroin fiber using electrostatic spinning process, optical cross-linking method is recycled to be coated on polyethylene glycol hydrogel Its surface forms composite material.Heart valve prosthesis prosthese is finally made in composite material sewing on bracket.Detailed process is such as Under:
(1) it prepares silk fibroin protein solution: natural silk is taken, after degumming, drying, dissolution, dialysis and concentration step Silk fibroin protein solution is made.
(2) electrostatic spinning fiber material: electrospinning device is worked in peace and contentment development in science and technology Co., Ltd SS- using Beijing Yongkang 3535H type electrostatic spinning machine, electrostatic spinning process are as follows: by the silk fibroin protein solution and polyethylene oxide (molecule after concentration Amount~300000) solution mixing system is at spinnability silk fibroin protein solution.Then prepared spinnability fibroin is drawn with syringe Syringe is fixed in the card slot of syringe pump by protein solution, and positive high voltage power supply is connected on front end of the syringe needle metal needle, Aluminium-foil paper is pasted in reception device and carries out fiber collection, and receiver end connects negative high voltage power source.It is carried out after setting spinning parameter Electrostatic spinning obtains fibroin fiber film.The tunica fibrosa prepared is carefully torn from aluminium-foil paper, is immersed in methanol solution In to obtain partially-crystallized fibroin albumen.
(3) penetration type punching is carried out to fibroin protein film using hyperfine machine table, avoids being layered and increasing its connectivity. Fibroin protein film is immersed in the PEGDA containing photoinitiator in advance in glue solution, being put into vacuum tank makes fibroin albumen The pre- gelling solution of PEGDA is completely filled in membrane fiber grid and hole.
(4) dimethyl silicone polymer (polydimethylsiloxane, PDMS) template of size and thickness needed for preparing, The PDMS template, which is placed on, a piece of to be hadOn the glass slide of coating, after then placing pretreatment in PDMS template Fibroin albumen membrane sample, be supplemented the pre- gelling solution of PEGDA and fill up PDMS template central clear region, then in PDMS template Covering another above hasThe glass slide of coating seals;
(5) using cool white light or ultraviolet light cross-linking until forming the composite wood of the coated fibroin protein film of polyethylene glycol hydrogel Material.
(6) fibroin protein film is cut into specific dimensions, and is sutured in internal stent with suture and the heart is made Dirty valve prosthesis guarantees that the fit-state of three leaflets under natural conditions is good after suture.
Embodiment 1
This example uses the anisotropy fibroin fiber composite material of polyethylene glycol hydrogel cladding, prepares stent diameter For the heart valve prosthesis prosthese of 25mm.
1. preparing silk fibroin protein solution: taking natural silk, made after degumming, drying, dissolution, dialysis and concentration step At silk fibroin protein solution.
2. electrostatic spinning prepares fibrous material: by the silk fibroin protein solution and polyethylene oxide (molecular weight after concentration ~300000) solution mixing system is at spinnability silk fibroin protein solution.In low silk fibroin protein solution concentration, (spinnability fibroin albumen is molten The content of silk fibroin protein solution is concentrated in liquid to carry out spinning under conditions of 10wt%), low spinning voltage (18kV), first uses roller It is placed on baffle again after receiver (revolution 2800rpm) collection acquisition anisotropic membrane and collects isotropic membrane, it is final to obtain Anisotropy duplicature (Fig. 1), 227.2 ± 23.0nm of average fibre diameter.
Mechanical test analysis shows, anisotropy fibroin fiber membrane material is being parallel to machine direction and perpendicular to fibre Tieing up has apparent Anisotropy on direction, elasticity modulus is respectively 12.11 ± 0.61MPa and 3.44 ± 0.29MPa, Close to the primary valvular elasticity modulus of human body.
3. carrying out penetration type punching to fibroin protein film using hyperfine machine table, pitch-row 2mm, aperture are about 100 μm. Fibroin protein film is immersed in the PEGDA solution for being 20% containing photoinitiator mass fraction, is vented under vacuum, makes fibroin egg PEGDA solution is completely filled in tunica albuginea fiber mesh and hole.
4. preparing the PDMS template that diameter is size needed for 25mm bracket, which is placed on a piece of glass slide, Then pretreated fibroin albumen membrane sample is placed in the white space in PDMS template, then is covered on PDMS template Another glass slide sealing;Using ultraviolet light cross-linking until forming the complex layered of the coated fibroin protein film of polyethylene glycol hydrogel Material (Fig. 2).
Mechanical test analysis shows, anisotropy fibroin fiber composite material be parallel to machine direction and perpendicular to In machine direction have apparent Anisotropy (Fig. 3), elasticity modulus be respectively 10.95 ± 1.09MPa and 3.55 ± 0.32MPa, close to the primary heart valve of human body.
5. fibroin albumen composite material is folded and is sutured according to mode shown in Fig. 4 (a), and will with suture It is sutured in internal stent (diameter 25mm) and is made heart valve prosthesis 4 (b), and when suture guarantees fibroin fiber along leaflet week To arrangement, guarantee that the fit-state of three leaflets under natural conditions is good after suture.
Fluid dynamics evaluation result shows that valve prosthesis has good flow dynamics (Fig. 5), effective vent Area is greater than 2.6cm2, reflux ratio reaches ISO-5840 standard less than 20%.
Embodiment 2
This example uses the anisotropy fibroin fiber composite material of polyethylene glycol hydrogel cladding, prepares stent diameter For the heart valve prosthesis prosthese of 23mm.
1. configuring fibroin albumen spinning solution: with embodiment 1.
2. electrostatic spinning prepares fibrous material: with embodiment 1.
3. coating PEGDA hydrogel: with embodiment 1.
4. fibroin albumen fiber composite material is cut out according to size needed for 23mm bracket, by fibroin fiber film according to Fig. 4 Shown mode is folded and is sutured, and is sutured in internal stent (diameter 23mm) with suture and heart valve is made Prosthese guarantees that fibroin fiber is circumferentially arranged along leaflet, guarantees the fitting of three leaflets under natural conditions after suture when suture It is in good condition.
Fluid dynamics evaluation result shows that valve prosthesis has good flow dynamics, effective vent area Greater than 2.1cm2, reflux ratio reaches ISO-5840 standard less than 7.8%.
Embodiment 3
This example uses the isotropism fibroin fiber composite material of polyethylene glycol hydrogel cladding, prepares stent diameter For the heart valve prosthesis prosthese of 25mm.
1. configuring fibroin albumen spinning solution: with embodiment 1.
2. electrostatic spinning prepares fibrous material: in low silk fibroin protein solution concentration (10wt.%), low spinning voltage (18kV) Under the conditions of, isotropic membrane is collected with baffle.The tunica fibrosa prepared is carefully torn from aluminium-foil paper, is immersed in methanol solution Obtain partially-crystallized fibroin protein film.
3. coating PEGDA hydrogel: with embodiment 1.
4. fibroin fiber film is cut out according to size needed for 25mm bracket, by fibroin fiber film according to shown in Fig. 4 Mode is folded and is sutured, and is sutured in internal stent (diameter 25mm) with suture and heart valve vacation is made Body guarantees that fibroin fiber is circumferentially arranged along leaflet, guarantees the fitting shape of three leaflets under natural conditions after suture when suture State is good.
Fluid dynamics evaluation result shows that valve prosthesis has good flow dynamics (Fig. 6), effective vent Area is greater than 2.3cm2, reflux ratio reaches ISO-5840 standard less than 14.5%.
Embodiment 4
This example is compound using isotropism fibroin fiber made from the different spinning parameters of polyethylene glycol hydrogel cladding Material prepares the heart valve prosthesis prosthese that stent diameter is 25mm.
1. configuring fibroin albumen spinning solution: with example 1.1.
2. in high fibroin albumen solution concentration (20wt.%), under high spinning voltage conditions (23kV), with baffle collect it is each to Same sex film.The tunica fibrosa prepared is carefully torn from aluminium-foil paper, methanol solution is immersed in and obtains partially-crystallized fibroin egg Tunica albuginea, 421.6 ± 151.9nm of fibroin fiber average diameter (Fig. 7).
3. coating PEGDA hydrogel: with embodiment 4.
3. sewing heart valve prosthesis: with embodiment 4.

Claims (10)

1. a kind of composite material based on fibroin fiber, it is characterised in that: the composite material includes fibroin fiber film With PEGDA hydrogel, there are multiple micropores on the fibroin fiber film, the PEGDA hydrogel is coated on fibroin albumen In tunica fibrosa both side surface, and the hydrogel has penetration type structure, it may be assumed that in fibroin fiber film both side surface PEGDA hydrogel is connected by the micropore.
2. the composite material according to claim 1 based on fibroin fiber, it is characterised in that: in the composite material, Volume ratio shared by the fibroin fiber film is 80%-100%, 100-700 μm of the film thickness of fibroin fiber film, fiber Average diameter 200-500nm.
3. the composite material according to claim 1 based on fibroin fiber, it is characterised in that: the fibroin albumen is fine Micropore on dimension film is uniformly distributed, and aperture is 100-150 μm, pitch-row 1-2mm.
4. the composite material according to claim 1 based on fibroin fiber, it is characterised in that: the fibroin albumen is fine Tieing up film is to be prepared using silk as raw material using electrostatic spinning process, in the electrostatic spinning process: spinning voltage range For 1-33kV, spinning receives distance 10-20cm, and spinning fltting speed is 0.1-0.15mm/min;During spinning, reception device When for aluminum baffle, isotropism fibroin protein film is obtained;When reception device is aluminum roller, anisotropy fibroin albumen is obtained Film.
5. the composite material according to claim 1 or 4 based on fibroin fiber, it is characterised in that: the fibroin egg When white fiber film is isotropism fibroin fiber film, isotropism arrangement is presented in fiber;The fibroin fiber film is When anisotropy fibroin fiber film, anisotropy arrangement is presented in fiber;The bullet of the isotropism fibroin fiber film Property modulus be 6-8MPa;In the anisotropy fibroin fiber film, it is parallel to machine direction elasticity modulus 13-18MPa, is hung down Directly in machine direction elasticity modulus be 1-4MPa.
6. the composite material according to claim 4 based on fibroin fiber, it is characterised in that: described to be based on fibroin egg The composite material of white fiber be by photo-crosslinking method by PEGDA hydrogel it is coated in fibroin fiber film surface obtain, should Process includes the following steps:
(1) pretreatment of fibroin fiber film: penetration type punching is carried out to fibroin protein film, is obtained multiple equally distributed micro- Hole avoids being layered and increasing its connectivity;Fibroin protein film after punching is immersed in the pre- plastic of the PEGDA containing photoinitiator In aqueous solution, be put into vacuum tank the fiber mesh for making fibroin protein film and be completely filled in hole (micropore) PEGDA in advance at Sol solution;
(2) the dimethyl silicone polymer template of size and thickness needed for preparing, which, which is placed on, a piece of hasOn the glass slide of coating, pretreated fibroin fiber membrane sample is then placed in PDMS template, It is supplemented the pre- gelling solution of PEGDA to fill up PDMS template central clear region, then cover another on PDMS template to haveThe glass slide of coating seals;
(3) reaction is crosslinked using cool white light or ultraviolet light, until forming the coated fibroin albumen of polyethylene glycol hydrogel The composite material of film.
7. the composite material according to claim 6 based on fibroin fiber, it is characterised in that: described in step (1) In the pre- gelling solution of PEGDA, PEGDA concentration is 20-30wt.%, photoinitiator concentration 1-5g/L, and the photoinitiator is Irgacure2959。
8. the composite material according to claim 6 based on fibroin fiber, it is characterised in that: in the composite material, When PEGDA hydrogel is coated when isotropism fibroin fiber film surface, Modulus of Composites 4-6MPa;When PEGDA hydrogel is coated, and composite material still maintains Anisotropy when anisotropy fibroin fiber film surface, In: it is parallel to machine direction elasticity modulus 11-15MPa, is 1-4MPa perpendicular to machine direction elasticity modulus.
9. using the heart valve prosthesis of the composite material production according to any one of claims 8 based on fibroin fiber, feature It is: by the composite material sewing based on fibroin fiber in internal stent, obtains anisotropy fibroin fiber Composite material heart valve prosthesis prosthese.
10. heart valve prosthesis according to claim 9, it is characterised in that: the heart valve prosthesis prosthese has excellent Different flow dynamics, effective vent area 1.5-2.7cm2, backflow than < 20%.
CN201910565441.9A 2019-06-27 2019-06-27 Composite material and heart valve prosthesis based on fibroin fiber Pending CN110279894A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910565441.9A CN110279894A (en) 2019-06-27 2019-06-27 Composite material and heart valve prosthesis based on fibroin fiber

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910565441.9A CN110279894A (en) 2019-06-27 2019-06-27 Composite material and heart valve prosthesis based on fibroin fiber

Publications (1)

Publication Number Publication Date
CN110279894A true CN110279894A (en) 2019-09-27

Family

ID=68007712

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910565441.9A Pending CN110279894A (en) 2019-06-27 2019-06-27 Composite material and heart valve prosthesis based on fibroin fiber

Country Status (1)

Country Link
CN (1) CN110279894A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112316219A (en) * 2020-09-29 2021-02-05 浙江大学 Anti-adhesion hydrogel-silk scaffold composite membrane and preparation and application thereof
CN112972770A (en) * 2021-02-22 2021-06-18 南通纺织丝绸产业技术研究院 Artificial heart valve with composite reinforced structure and preparation method thereof
CN113230455A (en) * 2021-05-13 2021-08-10 中国科学院金属研究所 Polyurethane/cellulose composite membrane, preparation method thereof and artificial heart valve prosthesis
CN113679890A (en) * 2021-08-16 2021-11-23 中国医学科学院生物医学工程研究所 Heart valve leaflet and preparation method thereof
WO2024041250A1 (en) * 2022-08-22 2024-02-29 杭州启明医疗器械股份有限公司 Polymer valve material, preparation method for integrally molding same, and use thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102133425A (en) * 2011-03-13 2011-07-27 苏州大学 Tussah silk fibroin film and preparation method thereof
CN103341209A (en) * 2013-07-08 2013-10-09 苏州大学 Silk fibroin nanofiber membrane and preparation method thereof
WO2017120371A1 (en) * 2016-01-08 2017-07-13 Cryolife, Inc. Human placental tissue graft products, methods, and apparatuses
CN105326581B (en) * 2015-09-29 2017-12-26 中国科学院金属研究所 A kind of method for preparing polyethylene glycol protein fiber composite heart valve prosthesis
CN108904877A (en) * 2018-08-10 2018-11-30 中国科学院金属研究所 Insertion type artificial cardiac valve and preparation method thereof based on macromolecular fibre composite material

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102133425A (en) * 2011-03-13 2011-07-27 苏州大学 Tussah silk fibroin film and preparation method thereof
CN103341209A (en) * 2013-07-08 2013-10-09 苏州大学 Silk fibroin nanofiber membrane and preparation method thereof
CN105326581B (en) * 2015-09-29 2017-12-26 中国科学院金属研究所 A kind of method for preparing polyethylene glycol protein fiber composite heart valve prosthesis
WO2017120371A1 (en) * 2016-01-08 2017-07-13 Cryolife, Inc. Human placental tissue graft products, methods, and apparatuses
CN108904877A (en) * 2018-08-10 2018-11-30 中国科学院金属研究所 Insertion type artificial cardiac valve and preparation method thereof based on macromolecular fibre composite material

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中国材料研究学会主编: "《纳米材料与技术应用进展 第四届全国纳米材料会议论文集》", 31 December 2005 *
杨力等: "《组织修复生物力学》", 31 December 2017 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112316219A (en) * 2020-09-29 2021-02-05 浙江大学 Anti-adhesion hydrogel-silk scaffold composite membrane and preparation and application thereof
CN112316219B (en) * 2020-09-29 2022-05-10 浙江大学 Anti-adhesion hydrogel-silk scaffold composite membrane and preparation and application thereof
CN112972770A (en) * 2021-02-22 2021-06-18 南通纺织丝绸产业技术研究院 Artificial heart valve with composite reinforced structure and preparation method thereof
CN113230455A (en) * 2021-05-13 2021-08-10 中国科学院金属研究所 Polyurethane/cellulose composite membrane, preparation method thereof and artificial heart valve prosthesis
CN113679890A (en) * 2021-08-16 2021-11-23 中国医学科学院生物医学工程研究所 Heart valve leaflet and preparation method thereof
WO2024041250A1 (en) * 2022-08-22 2024-02-29 杭州启明医疗器械股份有限公司 Polymer valve material, preparation method for integrally molding same, and use thereof

Similar Documents

Publication Publication Date Title
CN110279894A (en) Composite material and heart valve prosthesis based on fibroin fiber
Kong et al. Tissue-engineered cornea constructed with compressed collagen and laser-perforated electrospun mat
Zhang et al. Biocompatibility evaluation of bacterial cellulose as a scaffold material for tissue-engineered corneal stroma
Lee et al. Development of a composite vascular scaffolding system that withstands physiological vascular conditions
CN106492274B (en) Tissue repair tunica fibrosa and its preparation method and application and tissue repair product
CN114028603B (en) Double-layer asymmetric dressing for promoting skin wound repair and preparation method thereof
JPH04227264A (en) Collagen structural body
CN103480042B (en) Artificial dura mater spinalis, and preparation method and use method thereof
Strobel et al. Fabrication and characterization of electrospun polycaprolactone and gelatin composite cuffs for tissue engineered blood vessels
CN110193098B (en) Multilayer gradient biological membrane and preparation method thereof
CN106075578B (en) A kind of PLGA three-dimensional nerve conduit and preparation method thereof
CN106668944A (en) Three-layer composite small-caliber intravascular stent and preparation method thereof
CN110152065A (en) A kind of bionical micro-nano lamination hydrophobic biological valve and preparation method thereof
EP3854423B1 (en) Artificial dermis repair material and preparation method therefor
CN107789666A (en) A kind of inwall micro-patterning small-caliber artificial blood vessel
CN101703796A (en) Nano fibre artificial vascular graft modifying internal layer and preparation method thereof
CN106901866A (en) Compound dural patch for preventing adhesion and preparation method thereof
CN101417150A (en) The preparation method of aliphatic polyester-chitosan composite fiber tissue repair bracket
CN108210995A (en) A kind of novel composite biological tissues repair materials and its preparation method and application
CN107126576A (en) A kind of composite regenerated cellulosic wound dressings of kapok and preparation method thereof
CN117122740A (en) Rotator cuff tearing patch and preparation method thereof
US20200215228A1 (en) Collagen microfiber scaffolds
CN108888384B (en) Tubular stent with double-layer structure and preparation method thereof
CN111956865B (en) Nerve protection material, multilayer nerve repair catheter and preparation method thereof
CN113181433B (en) Vascularization promoting three-dimensional nanofiber tubular stent and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190927